Literature DB >> 9842906

Lack of p56lck expression correlates with CD4 endocytosis in primary lymphoid and myeloid cells.

A Pelchen-Matthews1, R P da Silva, M J Bijlmakers, N Signoret, S Gordon, M Marsh.   

Abstract

In cell lines the endocytic properties of CD4 are regulated through its association with the src-family tyrosine kinase p56lck. In lymphoid cell lines expressing p56lck, CD4 is restricted to the cell surface and undergoes only limited internalization. Phosphorylation of the cytoplasmic domain of CD4 causes p56lck to dissociate and activates an endocytosis signal leading to the internalization of CD4 through clathrin-coated pits. In p56lck-negative transfected cell lines CD4 is constitutively internalized, but internalization is inhibited when p56lck is expressed in these cells. We now demonstrate that these endocytic properties of CD4 determined in transfected cell lines hold true for CD4 naturally expressed on myeloid cell lines (HL-60 and U937), as well as on primary lymphocytes, monocytes and macrophages isolated from human blood. CD4 showed limited internalization on p56lck-positive lymphocytes, but was rapidly internalized in p56lck-negative monocytes and macrophages. Surprisingly, rapid internalization of CD4 was seen with the lymphocytes from one unidentified donor. In these cells we failed to detect p56lck expression by Western blotting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842906     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Down regulation of CD4 expression following isolation and culture of human monocytes.

Authors:  G M Graziani-Bowering; L G Filion
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages.

Authors:  Brian Tomkowicz; Chuhee Lee; Vipa Ravyn; Ricky Cheung; Andrzej Ptasznik; Ronald G Collman
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

3.  Di-leucine signals mediate targeting of tyrosinase and synaptotagmin to synaptic-like microvesicles within PC12 cells.

Authors:  A D Blagoveshchenskaya; E W Hewitt; D F Cutler
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

Review 4.  Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.

Authors:  Jeremiah F Roeth; Kathleen L Collins
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

5.  Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking.

Authors:  Joong Kyu Kim; Mark Klinger; Jonathan Benjamin; Yuanyuan Xiao; David J Erle; Dan R Littman; Nigel Killeen
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

Review 6.  Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?

Authors:  A Boasso; G M Shearer; C Chougnet
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

7.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 8.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

9.  Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.

Authors:  Nadine Laguette; Christelle Brégnard; Jérôme Bouchet; Alexandre Benmerah; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

10.  CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection.

Authors:  Anjie Zhen; Stephan R Krutzik; Bernard R Levin; Saro Kasparian; Jerome A Zack; Scott G Kitchen
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.